Description
Book SynopsisVolume 19 studies the binding capabilities of cariprazine, clozapine, risperidone, olazapine, quentiapine, ziprazidone, aripirazole, haloperidol, blonanserin, iloperidone, eticlopride, amisulpride and nemonapride. The comprehensive understanding of the molecular-level mechanisms of drug-induced side effects associated with cardiovascular diseases is of paramount importance for the effective management of schizophrenia. Thoracic aortic surgery has undergone major changes in the last two decades, resulting in more favourable short- and long-term outcomes. Better understanding of underlying pathologies, re-definition of guidelines and classifications, and the evolution of diagnostics, intraoperative techniques, postoperative care and post-discharge outpatient follow-up have collectively contributed to this success. The authors summarize the cornerstones of this evolvement. The various features of the different systems and devices for complete closure of the patent foramen ovale tunnel are described, highlighting findings that are useful for interventional cardiologists. Lastly, the inter-core laboratory variability of qualitative comparative analysis parameters is assessed in comparison to the intra-core laboratory variability in a randomized controlled trial evaluating drug-eluting stents.
Table of ContentsPreface; Theoretical Analysis of the Binding Capability of Therapeutics for Management of Schizophrenia of Dopamine, Serotonin and Adrenergic Receptors and Its Conjunction with Cardiovascular Diseases; A Comprehensive Guide to New Directions in Thoracic Aortic Surgery; Percutaneous Closure of Patent Foramen Ovale: Advantages and Disadvantages of Various Systems and Devices; Validation of Angiographic Core Laboratory in the Era of Drug-Eluting Stent; Index.
